We are working on a project through which we develop an environmentally more suitable formalin fixative equivalent that fixes tissue samples equally well. The new glyoxal-based fixative would be less harmful to the user while retaining the properties of an efficient tissue fixative. It would also be compatible with all the processes carried out for diagnostic and scientific purposes, making them easier in some cases (e.g. IHC without antigen retrieval).
The project is co-financed with funds from the Proof of Innovative Concept Program (PoC) established by the Croatian Agency for SMEs, Innovations and Investments (HAMAG-BICRO).